Chief Executive Officer
+46 73 262 53 33
Karl is the CEO at Elypta. He previously led digitalization efforts as Chief Digital Officer at Praktikertjänst, Sweden’s largest private healthcare provider. Before that, he was a Principal in Arthur D. Little’s healthcare & life science practice where he spent eight years assisting clients with strategic challenges across pharma, diagnostics and medtech. Karl holds M.Sc. degrees in Bioengineering as well as in Innovation & Entrepreneurship from Chalmers University of Technology and an MBA from University of Cambridge.
Chief Scientific Officer
Francesco is a co-founder and the Chief Scientific Officer at Elypta. He was named MIT Innovators Under 35 in Europe in 2018 and Pioneer of the Year for the same list. He holds a Ph.D. in Systems Biology from Chalmers University of Technology and a M.Sc. in Chemical Engineering from the University of Padova. He has spent 5 years modeling cancer metabolism, using genome-scale metabolic networks and -omics data mining at Chalmers as well as a Visiting Scholar at University of California, San Diego. Francesco co-authored 16 scientific papers and submitted 3 patent applications as inventor. His research led him to the invention of Elypta’s diagnostic method.